Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — The 2022 American College of Rheumatology recommendations on integrative therapy in rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . Maximizing the disease-modifying benefits of methotrexate is one of the core principles behind the 2021 American ...

The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis. This is the ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced late-breaking data from the ...

This article was originally published by HCPLive. The American College of Rheumatology (ACR) released 2 clinical practice guidelines for the screening, monitoring, and treatment of interstitial lung ...

HAYWARD, Calif.--(BUSINESS WIRE)--Aqtual, Inc., a precision medicine company using its novel active chromatin cell-free DNA platform to develop products for chronic diseases and oncology, today ...

Since their first publication in 2010, the EULAR recommendations for the use of disease-modifying anti-rheumatic treatments (DMARDs) in people with RA have become a most important publication in the ...

Polypharmacy was linked to a lower likelihood of achieving remission and an increased risk for serious adverse events among patients with early rheumatoid arthritis. Polypharmacy (PP) was ...